カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の核医学画像診断薬市場2023年：企業・地域・タイプ・用途別分析

◆英語タイトル：Global Nuclear Medicine Imaging Agents Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが発行した調査報告書（GIR23SM7408）◆商品コード：GIR23SM7408
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2023年9月
◆ページ数：100
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥522,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥783,000見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,044,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界の核医学画像診断薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の核医学画像診断薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 核医学画像診断薬の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

核医学画像診断薬市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・フッ素18標識、炭素11標識、窒素13標識、酸素15標識、テクネチウム99標識、その他

用途別セグメント
・早期診断、臨床段階、治療評価

主要な市場プレーヤー
・GE HealthCare、Bracco Diagnostic、Guerbet、Mallinckrodt、Lantheus、Yantai Dongcheng、Foshan Rui Diao Pharmaceutical、Cardinal Health、Blue Earth Diagnostics、Bayer AG、Abx Advanced Biochemical、Eli Lilly and Company、Jubilant Pharma Limited、Navidea

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、核医学画像診断薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な核医学画像診断薬メーカーの企業概要、2019年～2022年までの核医学画像診断薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な核医学画像診断薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別核医学画像診断薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの核医学画像診断薬のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での核医学画像診断薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および核医学画像診断薬の産業チェーンを掲載しています。
・第14、15章では、核医学画像診断薬の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 核医学画像診断薬の概要
– タイプ別分析（2018年vs2022年vs2029年）：フッ素18標識、炭素11標識、窒素13標識、酸素15標識、テクネチウム99標識、その他
– 用途別分析（2018年vs2022年vs2029年）：早期診断、臨床段階、治療評価
– 世界の核医学画像診断薬市場規模・予測
– 世界の核医学画像診断薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– GE HealthCare、Bracco Diagnostic、Guerbet、Mallinckrodt、Lantheus、Yantai Dongcheng、Foshan Rui Diao Pharmaceutical、Cardinal Health、Blue Earth Diagnostics、Bayer AG、Abx Advanced Biochemical、Eli Lilly and Company、Jubilant Pharma Limited、Navidea
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：フッ素18標識、炭素11標識、窒素13標識、酸素15標識、テクネチウム99標識、その他
・用途別分析2018年-2029年：早期診断、臨床段階、治療評価
・核医学画像診断薬の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・核医学画像診断薬のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・核医学画像診断薬のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・核医学画像診断薬の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・核医学画像診断薬の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Nuclear Medicine Imaging Agents
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Nuclear Medicine Imaging Agents Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Fluorine 18 Labeling
1.3.3 Carbon 11 Labeling
1.3.4 Nitrogen 13 Labeling
1.3.5 Oxygen 15 Labeling
1.3.6 Technetium 99 Labeling
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Nuclear Medicine Imaging Agents Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Early Diagnosis
1.4.3 Clinical Stage
1.4.4 Treatment Evaluation
1.5 Global Nuclear Medicine Imaging Agents Market Size & Forecast
1.5.1 Global Nuclear Medicine Imaging Agents Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Nuclear Medicine Imaging Agents Sales Quantity (2018-2029)
1.5.3 Global Nuclear Medicine Imaging Agents Average Price (2018-2029)
2 Manufacturers Profiles
2.1 GE HealthCare
2.1.1 GE HealthCare Details
2.1.2 GE HealthCare Major Business
2.1.3 GE HealthCare Nuclear Medicine Imaging Agents Product and Services
2.1.4 GE HealthCare Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GE HealthCare Recent Developments/Updates
2.2 Bracco Diagnostic
2.2.1 Bracco Diagnostic Details
2.2.2 Bracco Diagnostic Major Business
2.2.3 Bracco Diagnostic Nuclear Medicine Imaging Agents Product and Services
2.2.4 Bracco Diagnostic Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bracco Diagnostic Recent Developments/Updates
2.3 Guerbet
2.3.1 Guerbet Details
2.3.2 Guerbet Major Business
2.3.3 Guerbet Nuclear Medicine Imaging Agents Product and Services
2.3.4 Guerbet Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Guerbet Recent Developments/Updates
2.4 Mallinckrodt
2.4.1 Mallinckrodt Details
2.4.2 Mallinckrodt Major Business
2.4.3 Mallinckrodt Nuclear Medicine Imaging Agents Product and Services
2.4.4 Mallinckrodt Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mallinckrodt Recent Developments/Updates
2.5 Lantheus
2.5.1 Lantheus Details
2.5.2 Lantheus Major Business
2.5.3 Lantheus Nuclear Medicine Imaging Agents Product and Services
2.5.4 Lantheus Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Lantheus Recent Developments/Updates
2.6 Yantai Dongcheng
2.6.1 Yantai Dongcheng Details
2.6.2 Yantai Dongcheng Major Business
2.6.3 Yantai Dongcheng Nuclear Medicine Imaging Agents Product and Services
2.6.4 Yantai Dongcheng Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Yantai Dongcheng Recent Developments/Updates
2.7 Foshan Rui Diao Pharmaceutical
2.7.1 Foshan Rui Diao Pharmaceutical Details
2.7.2 Foshan Rui Diao Pharmaceutical Major Business
2.7.3 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product and Services
2.7.4 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Foshan Rui Diao Pharmaceutical Recent Developments/Updates
2.8 Cardinal Health
2.8.1 Cardinal Health Details
2.8.2 Cardinal Health Major Business
2.8.3 Cardinal Health Nuclear Medicine Imaging Agents Product and Services
2.8.4 Cardinal Health Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Cardinal Health Recent Developments/Updates
2.9 Blue Earth Diagnostics
2.9.1 Blue Earth Diagnostics Details
2.9.2 Blue Earth Diagnostics Major Business
2.9.3 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product and Services
2.9.4 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Blue Earth Diagnostics Recent Developments/Updates
2.10 Bayer AG
2.10.1 Bayer AG Details
2.10.2 Bayer AG Major Business
2.10.3 Bayer AG Nuclear Medicine Imaging Agents Product and Services
2.10.4 Bayer AG Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bayer AG Recent Developments/Updates
2.11 Abx Advanced Biochemical
2.11.1 Abx Advanced Biochemical Details
2.11.2 Abx Advanced Biochemical Major Business
2.11.3 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product and Services
2.11.4 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Abx Advanced Biochemical Recent Developments/Updates
2.12 Eli Lilly and Company
2.12.1 Eli Lilly and Company Details
2.12.2 Eli Lilly and Company Major Business
2.12.3 Eli Lilly and Company Nuclear Medicine Imaging Agents Product and Services
2.12.4 Eli Lilly and Company Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Eli Lilly and Company Recent Developments/Updates
2.13 Jubilant Pharma Limited
2.13.1 Jubilant Pharma Limited Details
2.13.2 Jubilant Pharma Limited Major Business
2.13.3 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product and Services
2.13.4 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Jubilant Pharma Limited Recent Developments/Updates
2.14 Navidea
2.14.1 Navidea Details
2.14.2 Navidea Major Business
2.14.3 Navidea Nuclear Medicine Imaging Agents Product and Services
2.14.4 Navidea Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Navidea Recent Developments/Updates
3 Competitive Environment: Nuclear Medicine Imaging Agents by Manufacturer
3.1 Global Nuclear Medicine Imaging Agents Sales Quantity by Manufacturer (2018-2023)
3.2 Global Nuclear Medicine Imaging Agents Revenue by Manufacturer (2018-2023)
3.3 Global Nuclear Medicine Imaging Agents Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Nuclear Medicine Imaging Agents by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Nuclear Medicine Imaging Agents Manufacturer Market Share in 2022
3.4.2 Top 6 Nuclear Medicine Imaging Agents Manufacturer Market Share in 2022
3.5 Nuclear Medicine Imaging Agents Market: Overall Company Footprint Analysis
3.5.1 Nuclear Medicine Imaging Agents Market: Region Footprint
3.5.2 Nuclear Medicine Imaging Agents Market: Company Product Type Footprint
3.5.3 Nuclear Medicine Imaging Agents Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Nuclear Medicine Imaging Agents Market Size by Region
4.1.1 Global Nuclear Medicine Imaging Agents Sales Quantity by Region (2018-2029)
4.1.2 Global Nuclear Medicine Imaging Agents Consumption Value by Region (2018-2029)
4.1.3 Global Nuclear Medicine Imaging Agents Average Price by Region (2018-2029)
4.2 North America Nuclear Medicine Imaging Agents Consumption Value (2018-2029)
4.3 Europe Nuclear Medicine Imaging Agents Consumption Value (2018-2029)
4.4 Asia-Pacific Nuclear Medicine Imaging Agents Consumption Value (2018-2029)
4.5 South America Nuclear Medicine Imaging Agents Consumption Value (2018-2029)
4.6 Middle East and Africa Nuclear Medicine Imaging Agents Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Nuclear Medicine Imaging Agents Sales Quantity by Type (2018-2029)
5.2 Global Nuclear Medicine Imaging Agents Consumption Value by Type (2018-2029)
5.3 Global Nuclear Medicine Imaging Agents Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Nuclear Medicine Imaging Agents Sales Quantity by Application (2018-2029)
6.2 Global Nuclear Medicine Imaging Agents Consumption Value by Application (2018-2029)
6.3 Global Nuclear Medicine Imaging Agents Average Price by Application (2018-2029)
7 North America
7.1 North America Nuclear Medicine Imaging Agents Sales Quantity by Type (2018-2029)
7.2 North America Nuclear Medicine Imaging Agents Sales Quantity by Application (2018-2029)
7.3 North America Nuclear Medicine Imaging Agents Market Size by Country
7.3.1 North America Nuclear Medicine Imaging Agents Sales Quantity by Country (2018-2029)
7.3.2 North America Nuclear Medicine Imaging Agents Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Nuclear Medicine Imaging Agents Sales Quantity by Type (2018-2029)
8.2 Europe Nuclear Medicine Imaging Agents Sales Quantity by Application (2018-2029)
8.3 Europe Nuclear Medicine Imaging Agents Market Size by Country
8.3.1 Europe Nuclear Medicine Imaging Agents Sales Quantity by Country (2018-2029)
8.3.2 Europe Nuclear Medicine Imaging Agents Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Nuclear Medicine Imaging Agents Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Nuclear Medicine Imaging Agents Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Nuclear Medicine Imaging Agents Market Size by Region
9.3.1 Asia-Pacific Nuclear Medicine Imaging Agents Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Nuclear Medicine Imaging Agents Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Nuclear Medicine Imaging Agents Sales Quantity by Type (2018-2029)
10.2 South America Nuclear Medicine Imaging Agents Sales Quantity by Application (2018-2029)
10.3 South America Nuclear Medicine Imaging Agents Market Size by Country
10.3.1 South America Nuclear Medicine Imaging Agents Sales Quantity by Country (2018-2029)
10.3.2 South America Nuclear Medicine Imaging Agents Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Nuclear Medicine Imaging Agents Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Nuclear Medicine Imaging Agents Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Nuclear Medicine Imaging Agents Market Size by Country
11.3.1 Middle East & Africa Nuclear Medicine Imaging Agents Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Nuclear Medicine Imaging Agents Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Nuclear Medicine Imaging Agents Market Drivers
12.2 Nuclear Medicine Imaging Agents Market Restraints
12.3 Nuclear Medicine Imaging Agents Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Nuclear Medicine Imaging Agents and Key Manufacturers
13.2 Manufacturing Costs Percentage of Nuclear Medicine Imaging Agents
13.3 Nuclear Medicine Imaging Agents Production Process
13.4 Nuclear Medicine Imaging Agents Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Nuclear Medicine Imaging Agents Typical Distributors
14.3 Nuclear Medicine Imaging Agents Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Nuclear Medicine Imaging Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Nuclear Medicine Imaging Agents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GE HealthCare Basic Information, Manufacturing Base and Competitors
Table 4. GE HealthCare Major Business
Table 5. GE HealthCare Nuclear Medicine Imaging Agents Product and Services
Table 6. GE HealthCare Nuclear Medicine Imaging Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GE HealthCare Recent Developments/Updates
Table 8. Bracco Diagnostic Basic Information, Manufacturing Base and Competitors
Table 9. Bracco Diagnostic Major Business
Table 10. Bracco Diagnostic Nuclear Medicine Imaging Agents Product and Services
Table 11. Bracco Diagnostic Nuclear Medicine Imaging Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bracco Diagnostic Recent Developments/Updates
Table 13. Guerbet Basic Information, Manufacturing Base and Competitors
Table 14. Guerbet Major Business
Table 15. Guerbet Nuclear Medicine Imaging Agents Product and Services
Table 16. Guerbet Nuclear Medicine Imaging Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Guerbet Recent Developments/Updates
Table 18. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 19. Mallinckrodt Major Business
Table 20. Mallinckrodt Nuclear Medicine Imaging Agents Product and Services
Table 21. Mallinckrodt Nuclear Medicine Imaging Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Mallinckrodt Recent Developments/Updates
Table 23. Lantheus Basic Information, Manufacturing Base and Competitors
Table 24. Lantheus Major Business
Table 25. Lantheus Nuclear Medicine Imaging Agents Product and Services
Table 26. Lantheus Nuclear Medicine Imaging Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Lantheus Recent Developments/Updates
Table 28. Yantai Dongcheng Basic Information, Manufacturing Base and Competitors
Table 29. Yantai Dongcheng Major Business
Table 30. Yantai Dongcheng Nuclear Medicine Imaging Agents Product and Services
Table 31. Yantai Dongcheng Nuclear Medicine Imaging Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Yantai Dongcheng Recent Developments/Updates
Table 33. Foshan Rui Diao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Foshan Rui Diao Pharmaceutical Major Business
Table 35. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product and Services
Table 36. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Foshan Rui Diao Pharmaceutical Recent Developments/Updates
Table 38. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 39. Cardinal Health Major Business
Table 40. Cardinal Health Nuclear Medicine Imaging Agents Product and Services
Table 41. Cardinal Health Nuclear Medicine Imaging Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Cardinal Health Recent Developments/Updates
Table 43. Blue Earth Diagnostics Basic Information, Manufacturing Base and Competitors
Table 44. Blue Earth Diagnostics Major Business
Table 45. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product and Services
Table 46. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Blue Earth Diagnostics Recent Developments/Updates
Table 48. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 49. Bayer AG Major Business
Table 50. Bayer AG Nuclear Medicine Imaging Agents Product and Services
Table 51. Bayer AG Nuclear Medicine Imaging Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Bayer AG Recent Developments/Updates
Table 53. Abx Advanced Biochemical Basic Information, Manufacturing Base and Competitors
Table 54. Abx Advanced Biochemical Major Business
Table 55. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product and Services
Table 56. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Abx Advanced Biochemical Recent Developments/Updates
Table 58. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 59. Eli Lilly and Company Major Business
Table 60. Eli Lilly and Company Nuclear Medicine Imaging Agents Product and Services
Table 61. Eli Lilly and Company Nuclear Medicine Imaging Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Eli Lilly and Company Recent Developments/Updates
Table 63. Jubilant Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 64. Jubilant Pharma Limited Major Business
Table 65. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product and Services
Table 66. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Jubilant Pharma Limited Recent Developments/Updates
Table 68. Navidea Basic Information, Manufacturing Base and Competitors
Table 69. Navidea Major Business
Table 70. Navidea Nuclear Medicine Imaging Agents Product and Services
Table 71. Navidea Nuclear Medicine Imaging Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Navidea Recent Developments/Updates
Table 73. Global Nuclear Medicine Imaging Agents Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Nuclear Medicine Imaging Agents Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Nuclear Medicine Imaging Agents Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Nuclear Medicine Imaging Agents, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Nuclear Medicine Imaging Agents Production Site of Key Manufacturer
Table 78. Nuclear Medicine Imaging Agents Market: Company Product Type Footprint
Table 79. Nuclear Medicine Imaging Agents Market: Company Product Application Footprint
Table 80. Nuclear Medicine Imaging Agents New Market Entrants and Barriers to Market Entry
Table 81. Nuclear Medicine Imaging Agents Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Nuclear Medicine Imaging Agents Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Nuclear Medicine Imaging Agents Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Nuclear Medicine Imaging Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Nuclear Medicine Imaging Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Nuclear Medicine Imaging Agents Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Nuclear Medicine Imaging Agents Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Nuclear Medicine Imaging Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Nuclear Medicine Imaging Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Nuclear Medicine Imaging Agents Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Nuclear Medicine Imaging Agents Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Nuclear Medicine Imaging Agents Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Nuclear Medicine Imaging Agents Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Nuclear Medicine Imaging Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Nuclear Medicine Imaging Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Nuclear Medicine Imaging Agents Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Nuclear Medicine Imaging Agents Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Nuclear Medicine Imaging Agents Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Nuclear Medicine Imaging Agents Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Nuclear Medicine Imaging Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Nuclear Medicine Imaging Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Nuclear Medicine Imaging Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Nuclear Medicine Imaging Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Nuclear Medicine Imaging Agents Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Nuclear Medicine Imaging Agents Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Nuclear Medicine Imaging Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Nuclear Medicine Imaging Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Nuclear Medicine Imaging Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Nuclear Medicine Imaging Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Nuclear Medicine Imaging Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Nuclear Medicine Imaging Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Nuclear Medicine Imaging Agents Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Nuclear Medicine Imaging Agents Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Nuclear Medicine Imaging Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Nuclear Medicine Imaging Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Nuclear Medicine Imaging Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Nuclear Medicine Imaging Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Nuclear Medicine Imaging Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Nuclear Medicine Imaging Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Nuclear Medicine Imaging Agents Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Nuclear Medicine Imaging Agents Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Nuclear Medicine Imaging Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Nuclear Medicine Imaging Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Nuclear Medicine Imaging Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Nuclear Medicine Imaging Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Nuclear Medicine Imaging Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Nuclear Medicine Imaging Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Nuclear Medicine Imaging Agents Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Nuclear Medicine Imaging Agents Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Nuclear Medicine Imaging Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Nuclear Medicine Imaging Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Nuclear Medicine Imaging Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Nuclear Medicine Imaging Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Nuclear Medicine Imaging Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Nuclear Medicine Imaging Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Nuclear Medicine Imaging Agents Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Nuclear Medicine Imaging Agents Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Nuclear Medicine Imaging Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Nuclear Medicine Imaging Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Nuclear Medicine Imaging Agents Raw Material
Table 141. Key Manufacturers of Nuclear Medicine Imaging Agents Raw Materials
Table 142. Nuclear Medicine Imaging Agents Typical Distributors
Table 143. Nuclear Medicine Imaging Agents Typical Customers
List of Figures
Figure 1. Nuclear Medicine Imaging Agents Picture
Figure 2. Global Nuclear Medicine Imaging Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Nuclear Medicine Imaging Agents Consumption Value Market Share by Type in 2022
Figure 4. Fluorine 18 Labeling Examples
Figure 5. Carbon 11 Labeling Examples
Figure 6. Nitrogen 13 Labeling Examples
Figure 7. Oxygen 15 Labeling Examples
Figure 8. Technetium 99 Labeling Examples
Figure 9. Others Examples
Figure 10. Global Nuclear Medicine Imaging Agents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 11. Global Nuclear Medicine Imaging Agents Consumption Value Market Share by Application in 2022
Figure 12. Early Diagnosis Examples
Figure 13. Clinical Stage Examples
Figure 14. Treatment Evaluation Examples
Figure 15. Global Nuclear Medicine Imaging Agents Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Nuclear Medicine Imaging Agents Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Nuclear Medicine Imaging Agents Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Nuclear Medicine Imaging Agents Average Price (2018-2029) & (US$/Unit)
Figure 19. Global Nuclear Medicine Imaging Agents Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Nuclear Medicine Imaging Agents Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Nuclear Medicine Imaging Agents by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Nuclear Medicine Imaging Agents Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Nuclear Medicine Imaging Agents Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Nuclear Medicine Imaging Agents Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Nuclear Medicine Imaging Agents Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Nuclear Medicine Imaging Agents Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Nuclear Medicine Imaging Agents Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Nuclear Medicine Imaging Agents Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Nuclear Medicine Imaging Agents Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Nuclear Medicine Imaging Agents Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Nuclear Medicine Imaging Agents Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Nuclear Medicine Imaging Agents Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Nuclear Medicine Imaging Agents Average Price by Type (2018-2029) & (US$/Unit)
Figure 34. Global Nuclear Medicine Imaging Agents Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Nuclear Medicine Imaging Agents Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Nuclear Medicine Imaging Agents Average Price by Application (2018-2029) & (US$/Unit)
Figure 37. North America Nuclear Medicine Imaging Agents Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Nuclear Medicine Imaging Agents Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Nuclear Medicine Imaging Agents Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Nuclear Medicine Imaging Agents Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Nuclear Medicine Imaging Agents Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Nuclear Medicine Imaging Agents Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Nuclear Medicine Imaging Agents Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Nuclear Medicine Imaging Agents Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Nuclear Medicine Imaging Agents Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Nuclear Medicine Imaging Agents Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Nuclear Medicine Imaging Agents Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Nuclear Medicine Imaging Agents Consumption Value Market Share by Region (2018-2029)
Figure 57. China Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Nuclear Medicine Imaging Agents Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Nuclear Medicine Imaging Agents Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Nuclear Medicine Imaging Agents Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Nuclear Medicine Imaging Agents Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Nuclear Medicine Imaging Agents Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Nuclear Medicine Imaging Agents Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Nuclear Medicine Imaging Agents Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Nuclear Medicine Imaging Agents Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Nuclear Medicine Imaging Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Nuclear Medicine Imaging Agents Market Drivers
Figure 78. Nuclear Medicine Imaging Agents Market Restraints
Figure 79. Nuclear Medicine Imaging Agents Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Nuclear Medicine Imaging Agents in 2022
Figure 82. Manufacturing Process Analysis of Nuclear Medicine Imaging Agents
Figure 83. Nuclear Medicine Imaging Agents Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の核医学画像診断薬市場2023年：企業・地域・タイプ・用途別分析(Global Nuclear Medicine Imaging Agents Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の核医学診断装置市場2023年：企業・地域・タイプ・用途別分析
  • 世界の超音波画像用マイクロバブル造影剤市場2023年：企業・地域・タイプ・用途別分析
  • 世界の細胞イメージングマイクロプレート検出装置市場2023年：企業・地域・タイプ・用途別分析
  • 世界の中医学用煎じ薬ポット市場2023年：企業・地域・タイプ・用途別分析
  • 世界のライブセルアッセイイメージングシステム市場2023年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆